BioTech/Drugs - New York, NY, US
Ceramedix is a growing, privately- and government-funded biotechnology company developing a new class of tissue protection and repair medicines pioneered by leading scientific and clinical experts in these areas. Our scientific founders at Memorial Sloan Kettering Cancer Center in New York have formed a deep, mechanistic understanding of a novel signaling biology that drives tissue injury in a broad range of medically relevant settings. We believe our drug candidates will have application for treating multiple inflammatory and immune-mediated diseases, including those that affect the vascular endothelium, eye, lung and other organs. We are located in New York City.
Outlook
Google AdSense
Google Cloud Hosting
Mobile Friendly